VX-759
VX-759 (VCH-759) is an orally active HCV NS5B RNA-dependent RNA polymerase inhibitor. VX-759 is promising for research of chronic hepatitis C[1].
Product Specifications
CAS Number
[478025-29-5]
Product Name Alternative
VCH-759
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
HCV; HCV Protease
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C([C@@H]1CC[C@H](CC1)C)N(C2=C(SC(C3=CC=CC=C3)=C2)C(O)=O)C(C)C
Molecular Formula
C22H27NO3S
Molecular Weight
385.52
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Cooper C, et al. Evaluation of VCH-759 monotherapy in hepatitis C infection. J Hepatol. 2009 Jul;51 (1) :39-46. doi: 10.1016/j.jhep.2009.03.015. Epub 2009 Apr 23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15088623 1 Vial
Lentiviral human SELENOM shRNA (UAS) - Lentiviral human SELENOM shRNA (UAS, iRFP) (100)
Ask
View Details 